On January 17, 2019, the Institute of Biomedical Sciences of Shanxi University (IBMS) and Shanghai Meiouhua Biotechnology Co., Ltd. (Meiouhua) held a signing ceremony on cooperation of "Stem Cell Technology Innovation and Application". With unique and complementary advantages of each other side’s, they will jointly promote the innovation and application of stem cell technology by sharing resources, benefits and learning from each other.

IBMS is the first biomedical research institute in the central and western regions of China. Thanks to the support by the “Scheme for Promotion of One Institution One Province of the Central Government”, IBMS has both excellent facilities with state-of-the-art laboratories and talented teams for cutting-edge researches.

Professor Changxin Wu as the Dean of IBMS, Professor Jinpei Ye as the Chair of stem cell research, Dr. Ruixi Qin as the Chairman of Meiouhua, and Mr. Yizhen Wang as the Executive President, delivered speeches on the ceremony. The project leaders of both sides for this cooperation took a consensus “to work together and share together achievements for the goal of stem cell technology innovation and application in regenerative medicine”.

This “strong-strong” combination of IBMS and Meiouhua is destined to become a milestone in the development of stem cell technology not only in Shanxi Province but also in China, and to channel through a mainstream for industrialization of stem cell technology for clinical applications especially in cosmetic and plastic surgery as well as rejuvenation in the field.